Recipharm AB: Invitation to Presentation of Recipharm’s Interim Report for the Second Quarter of 2014 on August 14Th

Regulatory News:

Recipharm AB (STO:RECI):

The company invites investors, analysts and media to a conference call with a web presentation (in English) on August 14 at 10:00 CET, where CEO Thomas Eldered and CFO Björn Westberg will present and comment on the interim report and answer questions.

The report will be available on Recipharm’s website www.recipharm.com from 07:45 CET the same day.

To participate in the teleconference, please dial:

From Sweden, tel: +46 8 506 443 86

From Denmark, tel: +45 32 71 42 62

From Finland, tel: +358 9 8171 0375

From Norway, tel: +47 21 06 61 13

From the UK, tel: +44 20 7153 9154

From Germany, tel: +49 69 2017 44 210

From France, tel: +33 1 70 70 95 02

From Spain, tel: +34 914 142 009

From Switzerland, tel: +41 44 580 65 22

From the US, tel:+1 877 423 0830

Pin code for participants: 971786#

To access the presentation during the conference, please use the following link: http://event.onlineseminarsolutions.com/r.htm?e=812271&s=1&k=E98891B7E670CAB2F482FB64869F866C

To access the presentation afterwards, please use the following link: http://event.onlineseminarsolutions.com/r.htm?e=812271&s=1&k=E98891B7E670CAB2F482FB64869F866C

Recipharm AB (publ)

Corporate identity number 556498-4825

Address Lagervägen 7, SE-136 50 Jordbro Telephone 46 8 602 52 00

Fax 46 8 81 87 03, www.recipharm.com

This information was brought to you by Cision http://news.cision.com